Phosphorylcholine or heparin coating for pediatric extracorporeal circulation causes similar biologic effects in neonates and infants.

[1]  D. De Wolf,et al.  Phosphorylcholine coating of extracorporeal circuits provides natural protection against blood activation by the material surface. , 2000, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[2]  A. Galloway,et al.  Impact of heparin bonding on pediatric cardiopulmonary bypass: a prospective randomized study. , 2000, The Annals of thoracic surgery.

[3]  J. Pincemail,et al.  Cytokine release and neutrophil activation are not prevented by heparin-coated circuits and aprotinin administration. , 2000, The Annals of thoracic surgery.

[4]  Y. Takanashi,et al.  Clinical efficacy of heparin-bonded bypass circuits related to cytokine responses in children. , 2000, The Annals of thoracic surgery.

[5]  J. Maessen,et al.  Impact of blood transfusions on inflammatory mediator release in patients undergoing cardiac surgery. , 1999, Chest.

[6]  S. Chihara,et al.  Inhibitory effect of milrinone on cytokine production after cardiopulmonary bypass. , 1999, The Annals of thoracic surgery.

[7]  C. Brizard,et al.  IL-6 and IL-8 levels after cardiopulmonary bypass are not affected by surface coating. , 1999, The Annals of thoracic surgery.

[8]  A. Stammers,et al.  Quantitative evaluation of heparin-coated versus non-heparin-coated bypass circuits during cardiopulmonary bypass. , 1999, The journal of extra-corporeal technology.

[9]  J. Vincent,et al.  Does steroid pretreatment increase endotoxin release during clinical cardiopulmonary bypass? , 1999, The Journal of thoracic and cardiovascular surgery.

[10]  S. Zahler,et al.  Sodium nitroprusside during coronary artery bypass grafting: evidence for an antiinflammatory action. , 1999, The Annals of thoracic surgery.

[11]  C. Baufreton,et al.  Inflammatory response to cardiopulmonary bypass using roller or centrifugal pumps. , 1999, The Annals of thoracic surgery.

[12]  R. W. Logan,et al.  Acute-phase responses to cardiopulmonary bypass in children weighing less than 10 kilograms. , 1996, The Annals of thoracic surgery.

[13]  E. Fosse,et al.  Complement and granulocyte activation in two different types of heparinized extracorporeal circuits. , 1995, The Journal of thoracic and cardiovascular surgery.

[14]  G. von Bernuth,et al.  Complement activation during cardiopulmonary bypass in infants and children. Relation to postoperative multiple system organ failure. , 1993, The Journal of thoracic and cardiovascular surgery.

[15]  J. Weiler,et al.  Cytokine and complement levels in patients undergoing cardiopulmonary bypass. , 1993, The Journal of thoracic and cardiovascular surgery.

[16]  D. Machin,et al.  Medical Statistics: A Commonsense Approach , 1993 .

[17]  S Westaby,et al.  Inflammatory response to cardiopulmonary bypass. , 1993, The Annals of thoracic surgery.